文献速递心律失常

冷冻球囊消融作为房颤初始治疗的JACC综述

Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

房颤是临床最常见的持续性心律失常,呈慢性进展性。指南推荐抗心律失常药物作为维持窦律的初始治疗,但疗效有限且不良反应明显。综述指出,对初治房颤患者采用冷冻球囊导管消融作为初始策略,可显著改善心律失常结局、患者报告结局并减少住院,且不增加严重或任何不良事件风险。

要点

  • 冷冻球囊消融作为初治房颤的初始策略,可显著改善无心律失常生存。
  • 该策略可改善症状与生活质量,并减少后续住院等医疗资源使用。
  • 与初始抗心律失常药物相比,不增加严重或任何不良事件风险。

核心结论

  • 对初治房颤患者,冷冻球囊导管消融作为初始治疗策略可改善心律失常结局与患者报告结局,减少住院,且不增加不良事件风险。

研究设计与样本

  • JACC State-of-the-Art Review(综述),检索范围原文未报告。

主要发现

  • 初治房颤患者以冷冻球囊消融为初始策略,可显著提高无任何或症状性房性快速性心律失常生存。
  • 该策略在患者报告的症状与生活质量方面产生具有临床意义的改善。
  • 该策略显著减少后续住院等医疗资源使用。
  • 与初始抗心律失常药物治疗相比,不增加严重或任何不良事件风险。

临床怎么用

  • 可为初治房颤患者在初始节律控制治疗选择上提供参考,兼顾心律失常控制、症状改善与医疗资源使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atrial fibrillation (AF), the most common sustained arrhythmia observed in clinical practice, is a chronic and progressive disorder characterized by exacerbations and remissions. Guidelines recommend antiarrhythmic drugs as the initial therapy for the maintenance of sinus rhythm; however, antiarrhythmic drugs have modest efficacy to maintain sinus rhythm and can be associated with significant adverse effects. An initial treatment strategy of cryoballoon catheter ablation in patients with treatment-naïve AF has been shown to significantly improve arrhythmia outcomes (freedom from any, or symptomatic atrial tachyarrhythmia), produce clinically meaningful improvements in patient-reported outcomes (symptoms and quality of life), and significantly reduce subsequent health care resource use (hospitalization), and it does not increase the risk of serious or any adverse events compared with initial antiarrhythmic drug therapy. These findings are relevant to inform patients, providers, and health care systems regarding the initial choice of rhythm-control therapy in patients with treatment-naïve AF.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Andrade JG, Wazni OM, Kuniss M, et al. Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021. PMID: 34446164. doi:10.1016/j.jacc.2021.06.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。